Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.
about
Mucins in cancer: function, prognosis and therapyDistinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and PrognosticsIsolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigenHuman prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.Functional targeting of the MUC1 oncogene in human cancersCurrent approaches and challenges in monitoring treatment responses in breast cancer.Transmembrane mucins as novel therapeutic targetsGene-based vaccines and immunotherapeutics.Serum human alpha-lactalbumin as a marker for breast cancer.Polymorphic epithelial mucin from the sera of advanced breast cancer patients--isolation and partial characterisation.A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer.An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma.Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.Circulating CA 15-3 antigen levels in non-mammary malignancies.Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.Update on Mucin-1 immunotherapy in cancer: a clinical perspective.Antibodies to human milk fat globule molecules.TG4010: a vaccine with a therapeutic role in cancer.Method comparison for CA 15-3, CA 19-9, and CA 125 determination using the new LOCI technique of Dimension Vista 1500 and Immulite 2000 XPI.Construction of immunoradiometric assay for circulating c-erbB-2 protooncogene product in advanced breast cancer patients.Recognition of the polypeptide core of mucin by monoclonal antibody MUSE11 against an adenocarcinoma-associated antigen.
P2860
Q24633765-5D926DD4-9970-44C3-8487-F2866839F11EQ24810591-A36CD1BA-F115-4F45-8AB7-F5B8C905E4B6Q26778227-E5CAEB99-09B7-4340-A2B2-A4A1EAC81CF1Q33564580-DC03B52A-9CB5-4D5F-B184-5AAA7E7EE1F4Q33728631-2274F770-4DD0-4FDB-8CB4-F7B2F202A83CQ33837694-8DBD2206-EE31-4C23-8057-990366215667Q34315017-2FCFFB4C-5BC2-450A-8F7B-3A52915B9263Q34558072-5A8B0F85-C7E8-4469-AD0F-A01EE1CDA4B2Q34658727-7B875C66-B97C-4531-A3CB-34AA2576D110Q35632645-BB62926E-14F6-456B-892A-2A2026386DD4Q35873176-EE55E96D-0617-4B82-B169-61CF6AF2587DQ35982461-9DCAEA67-D171-407C-8B55-9F3D57A8E701Q35982599-CF5AD909-05EA-491E-85F9-C9A87418E89AQ36027660-B7519770-17C9-4D6C-BD16-D1B8B1CB8B27Q36081093-A72DAA0F-8652-428C-BA86-2D0DA442240EQ36466048-E0BC8ED3-6F85-4378-936B-8454AD218208Q36467062-5BACFBD7-5329-4E83-B34D-A7B7F8975D35Q36467618-B520B0F2-99AF-4999-A6C1-060591325396Q36467846-918540DC-08F6-4D1B-BA93-3D8E86F95D96Q36753508-D4002842-400C-4D7F-8EC1-10F2FCD43EE1Q38603410-513B3173-9090-45D6-9CF1-3CF933686A2DQ38648451-E62A3AC2-0962-4FE6-90C2-7BDFE09631E3Q38824172-A2CCC2EC-CF84-4F44-83C7-846B7F5EB2CEQ50912876-08F2EE27-4438-4D30-AEAD-C69DF55A2A0EQ55194670-D886257E-4848-4AC7-B550-148F7BCAACA4Q55409136-9270CCE6-84D2-461E-8FD1-37D55715E860
P2860
Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.
description
1985 nî lūn-bûn
@nan
1985 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Use of a murine monoclonal ant ...... els in breast cancer patients.
@ast
Use of a murine monoclonal ant ...... els in breast cancer patients.
@en
Use of a murine monoclonal ant ...... els in breast cancer patients.
@nl
type
label
Use of a murine monoclonal ant ...... els in breast cancer patients.
@ast
Use of a murine monoclonal ant ...... els in breast cancer patients.
@en
Use of a murine monoclonal ant ...... els in breast cancer patients.
@nl
prefLabel
Use of a murine monoclonal ant ...... els in breast cancer patients.
@ast
Use of a murine monoclonal ant ...... els in breast cancer patients.
@en
Use of a murine monoclonal ant ...... els in breast cancer patients.
@nl
P2093
P2860
P356
P1476
Use of a murine monoclonal ant ...... els in breast cancer patients.
@en
P2093
P2860
P304
P356
10.1172/JCI111875
P407
P577
1985-05-01T00:00:00Z